한빛사논문
Abstract
Shin Jung C. Lee,a† Eunju Nam,a† Hyuck Jin Lee,b Masha G. Savelieffcd and Mi Hee Lim*a
a Department of Chemistry, Ulsan National Institute of Science and Technology (UNIST), Ulsan 44919, Republic of Korea
b School of Life Sciences, Ulsan National Institute of Science and Technology (UNIST), Ulsan 44919, Republic of Korea
c Department of Neurosurgery, University of Michigan, Ann Arbor 48109, USA
d SciGency Science Communications, Ann Arbor 48104, USA
* Corresponding author
†These authors contributed equally to this work.
Abstract
Alzheimer's disease (AD) is characterized by an imbalance between production and clearance of amyloid-β (Aβ) species. Aβ peptides can transform structurally from monomers into β-stranded fibrils via multiple oligomeric states. Among the various Aβ species, structured oligomers are proposed to be more toxic than fibrils; however, the identification of Aβ oligomers has been challenging due to their heterogeneous and metastable nature. Multiple techniques have recently helped us gain a better understanding of oligomers' assembly details and structural properties. Moreover, some progress on elucidating the mechanisms of oligomer-triggered toxicity has been made. Based on the collection of current findings, there is growing consensus that control of toxic Aβ oligomers could be a valid approach to regulate Aβ-associated toxicity, which could advance development of new diagnostics and therapeutics for amyloid-related diseases. In this review, we summarize the recent understanding of Aβ oligomers' assembly, structural properties, and toxicity, along with inhibitors against Aβ aggregation, including oligomerization.
논문정보
관련 링크
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기